C12Y 304/21107
Peptidase do
Official title: Peptidase Do (3.4.21.107)
C12Y304/21107 (Peptidase do) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 5
- Assignees
- 6
- Inventors
- 15
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Thrombolytic agents for intravascular clots4 Jun 2026US 2026/0151464 A1Jinis Co., Ltd.
- Engineered strain and the construction method and use thereof2 Apr 2026US 2026/0092295 A1Innobio Corporation Limited
- Protease Formulation for Treatment of Toxins11 Dec 2025US 2025/0375507 A1Kingston Health Sciences Centre
- Thrombolytic Agents for Intravascular Clots17 Nov 2022US 2022/0362355 A1Jinis Co., Ltd.
- Tobacco protease genes21 Sep 2017US 2017/0265516 A1Philip Morris Products S. A.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.